Matching placebo for Tezepelumab solution for injection, TEZEPELUMAB
D5180C00016
Phase 3 small_molecule active
Quick answer
Matching placebo for Tezepelumab solution for injection, TEZEPELUMAB for Severe Uncontrolled Asthma Asthma (an illness that causes breathing difficulty) that is not fully controlled, so that asthma attacks are still occurring despite the use of other available treatments is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Severe Uncontrolled Asthma Asthma (an illness that causes breathing difficulty) that is not fully controlled, so that asthma attacks are still occurring despite the use of other available treatments
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active